CSL Limited (ASX:CSL) Stock Outlook 2026: Is the Biotech Giant Finally a Buy After a 35% Sell-Off?
As of 9 December 2025 CSL Limited, long considered one of the most reliable growth names on the ASX, has just lived through one of the ugliest years in its listed history. After profit downgrades, a delayed spin-off, falling US